טוען...
Older Age of Rheumatoid Arthritis Onset and Comorbidities Correlates With Less HAQ-DI and CDAI Response to Etanercept in the RADIUS 2 Registry
BACKGROUND: Controversy exists in understanding the effects of age of onset and comorbidities in predicting rheumatoid arthritis (RA) response to biologic therapy. OBJECTIVE: To investigate the influence of age of onset and number of comorbidities on Health Assessment Questionnaire-Disability Index...
שמור ב:
| הוצא לאור ב: | J Clin Rheumatol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4560341/ https://ncbi.nlm.nih.gov/pubmed/25160011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000000152 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|